Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27478651 | 1.00 | TRPV1 (0.47) | TRPV1LMNATSHRHPGDALDH1A1 | |
| SCHEMBL8438807 | 1.00 | TRPV1 (0.47) | TRPV1LMNATSHRHPGDALDH1A1 | |
| SCHEMBL9059689 | 1.00 | TRPV1 (0.47) | TRPV1LMNATSHRHPGDALDH1A1 | |
| SCHEMBL8439341 | 0.88 | TRPV1 (0.47) | TRPV1LMNATSHRHPGDALDH1A1 | |
| SCHEMBL8442227 | 0.83 | KMT2A (0.43) | TRPV1LMNAKMT2AL3MBTL1ASAH1 | |
| SCHEMBL8439721 | 0.83 | KMT2A (0.43) | TRPV1LMNAKMT2AL3MBTL1ASAH1 | |
| SCHEMBL8439723 | 0.83 | KMT2A (0.43) | TRPV1LMNAKMT2AL3MBTL1ASAH1 | |
| SCHEMBL8439402 | 0.81 | KMT2A (0.43) | TRPV1LMNAHPGDALDH1A1KMT2A | |
| SCHEMBL8439400 | 0.81 | KMT2A (0.44) | TRPV1LMNAKMT2AASAH1 | |
| SCHEMBL8772503 | 0.80 | TRPV1 (0.48) | TRPV1LMNATSHRHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5990102-A | Substituted azetidin-2-ones for treatment of atherosclerosis | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-11-23 | — | — | US | claimed |
| WO-1996019451-A1 | SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1996-06-27 | — | — | WO | claimed |
| US-5990102-A | Substituted azetidin-2-ones for treatment of atherosclerosis | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-11-23 | — | — | US | disclosed |
| EP-0799200-A1 | SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1997-10-08 | — | — | EP | disclosed |
| WO-1996019451-A1 | SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1996-06-27 | — | — | WO | disclosed |